BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 166 filers reported holding BLUEBIRD BIO INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $80,937 | -7.6% | 26,624 | 0.0% | 0.01% | -16.7% |
| Q2 2023 | $87,593 | -37.6% | 26,624 | -39.7% | 0.01% | -14.3% |
| Q1 2023 | $140,314 | -54.0% | 44,124 | 0.0% | 0.01% | -62.2% |
| Q4 2022 | $305,338 | +9.3% | 44,124 | 0.0% | 0.04% | +15.6% |
| Q3 2022 | $279,305 | +13.5% | 44,124 | -25.9% | 0.03% | +52.4% |
| Q2 2022 | $246,000 | -64.0% | 59,524 | -57.7% | 0.02% | -27.6% |
| Q1 2022 | $683,000 | -54.7% | 140,824 | -6.6% | 0.03% | -68.5% |
| Q4 2021 | $1,507,000 | -65.7% | 150,824 | -34.5% | 0.09% | -67.3% |
| Q3 2021 | $4,397,000 | -36.1% | 230,100 | +7.0% | 0.28% | -34.3% |
| Q2 2021 | $6,876,000 | -4.2% | 215,000 | -9.7% | 0.43% | -5.7% |
| Q1 2021 | $7,176,000 | +2993.1% | 238,000 | +18207.7% | 0.45% | +1094.7% |
| Q4 2017 | $232,000 | – | 1,300 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 5,910,687 | $24,470,000 | 3.71% |
| Monaco Asset Management SAM | 306,142 | $1,267,000 | 0.55% |
| Parametrica Management Ltd | 90,105 | $374,000 | 0.41% |
| Kamunting Street Capital Management, L.P. | 55,200 | $229,000 | 0.31% |
| Birchview Capital, LP | 98,000 | $406,000 | 0.30% |
| Kamunting Street Capital Management, L.P. | 35,000 | $145,000 | 0.20% |
| PDT Partners, LLC | 519,477 | $2,151,000 | 0.19% |
| Graham Capital Management, L.P. | 781,912 | $3,237,000 | 0.13% |
| CAXTON ASSOCIATES LP | 220,154 | $911,000 | 0.09% |
| Baker Brothers Advisors | 2,499,715 | $10,349,000 | 0.06% |